GHRL and cancer: Additionally, changes in gastrointestinal hormones, such as ghrelin, GLP-1, and PYY, have been observed in metabolic syndrome and obesity, with emerging evidence suggesting that ghrelin may be specifically associated with cancer proliferation and metastasis (11).